- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Splenic flexure.
Displaying page 1 of 1.
EudraCT Number: 2008-007292-25 | Sponsor Protocol Number: GIU-5-ASA 1.2MMx-02-08 | Start Date*: 2009-03-24 | |||||||||||
Sponsor Name:GIULIANI | |||||||||||||
Full Title: AN OPEN, PILOT PHASE III, RANDOMIZED CLINICAL TRIAL TO ASSESS THE TISSUTAL PHARMAKINETICS OF MESALAZINE TABLETS IN PATIENTS WITH MILD TO MODERATE LEFT-SIDED ULCERATIVE COLITIS IN ACTIVE PHASE | |||||||||||||
Medical condition: Patients with established diagnosis of left-sided UC (rectum-sigmoid colon or colon up to the splenic flexure) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005090-13 | Sponsor Protocol Number: "Painstudy"1 | Start Date*: 2017-04-18 |
Sponsor Name:Cancer Registry of Norway | ||
Full Title: Reducing painful colonoscopies in women participating in a colorectal cancer screening program: A randomized controlled trial | ||
Medical condition: Many women are experiencing pain under colonoscopy. The present study aims to reduce pain in women undergoing colonoscopy in a bowel cancer screening program in Norway. | ||
Disease: | ||
Population Age: Elderly | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020943-10 | Sponsor Protocol Number: GA10/9312 | Start Date*: 2011-03-16 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme... | |||||||||||||
Medical condition: colorectal adenoma (polyp) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003304-39 | Sponsor Protocol Number: 007 | Start Date*: 2019-01-23 | ||||||||||||||||
Sponsor Name:Morten Rasmussen | ||||||||||||||||||
Full Title: Efficacy of a novel 1l PEG plus ascorbate (Plenvu) bowel preparation vs. 2l PEG plus ascorbate (Moviprep), a randomized controlled multicenter trial | ||||||||||||||||||
Medical condition: Bowel preparation before colonoscopy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002562-12 | Sponsor Protocol Number: ENDOS2019 | Start Date*: 2019-09-09 |
Sponsor Name:HOSPITAL GENERAL DE CATALUNYA | ||
Full Title: PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE IN THE EFFECTIVENESS OF SCREENING AND SURVE... | ||
Medical condition: Screening and surveillance colonoscopy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002549-13 | Sponsor Protocol Number: CSUC-01/21 | Start Date*: 2021-09-07 | |||||||||||
Sponsor Name:InDex Pharmaceuticals | |||||||||||||
Full Title: A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to ... | |||||||||||||
Medical condition: Moderate to Severe left-sided Active Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) DE (Ongoing) HU (Prematurely Ended) FR (Prematurely Ended) SK (Prematurely Ended) LT (Prematurely Ended) IT (Prematurely Ended) AT (Prematurely Ended) PT (Prematurely Ended) NO (Prematurely Ended) BE (Completed) DK (Prematurely Ended) HR (Prematurely Ended) NL (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001782-42 | Sponsor Protocol Number: CB-01-05/04 | Start Date*: 2006-12-20 | |||||||||||
Sponsor Name:Cosmo Technologies Ltd | |||||||||||||
Full Title: Efficacy and tolerability of a new oral extended-release formulation containing Low Molecular Weight Heparin (CB-01-05-MMX), administered as add-on therapy to oral mesalazine or other 5-ASA derivat... | |||||||||||||
Medical condition: Active left-sided, mild to moderate ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004217-26 | Sponsor Protocol Number: CSUC-01/16 | Start Date*: 2017-04-21 |
Sponsor Name:InDex Pharmaceuticals AB | ||
Full Title: A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis Patients | ||
Medical condition: Moderate to Severe left-sided Active Ulcerative Colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) SE (Completed) ES (Completed) CZ (Completed) FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000347-60 | Sponsor Protocol Number: TTD-18-01 | Start Date*: 2018-08-08 | |||||||||||
Sponsor Name:Grupo de Tratamiento de los Tumores Digestivos (TTD) | |||||||||||||
Full Title: Phase III randomized sequential open-label study to evaluate the efficacy of FOLFOX + panitumumab followed by FOLFIRI + bevacizumab (Sequence 1) versus FOLFOX + bevacizumab followed by FOLFIRI + pa... | |||||||||||||
Medical condition: metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) PT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001776-15 | Sponsor Protocol Number: MS202202-0002 | Start Date*: 2020-11-16 | |||||||||||
Sponsor Name:Merck Healthcare KGaA | |||||||||||||
Full Title: A Phase II single-arm study to investigate tepotinib combined with cetuximab in RAS/BRAF wild-type left-sided metastatic colorectal cancer (mCRC) patients having acquired resistance to anti-EGFR... | |||||||||||||
Medical condition: left-sided metastatic colorectal cancer (mCRC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Prematurely Ended) CZ (Prematurely Ended) BE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
